Olodaterol Oral Inhalation

316 interactions 36 cited references

Also sold as: Striverdi Striverdi® Respimat®

About Olodaterol Oral Inhalation

Olodaterol oral inhalation is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, which includes chronic bronchitis and emphysema). Olodaterol oral inhalation is in a class of medicatio… Read the full Olodaterol Oral Inhalation drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir Sparfloxacin

12 Contraindicated 247 Major 57 Moderate

All (316) Contraindicated (12) Major (247) Moderate (57)

Major

Olodaterol Oral Inhalation Linezolid Zyvox Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Lisdexamfetamine Arynta An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Lofepramine Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Lofexidine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Loperamide Diamode An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Lumefantrine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Macimorelin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Mavorixafor Xolremdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Mefloquine Lariam® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Melitracen Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Methacholine Inhibition of the airway response to methacholine Details Olodaterol Oral Inhalation Methadone Diskets An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Methamphetamine Desoxyn An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Methotrimeprazine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Methylene Blue Provayblue Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Methylphenidate Adhansia XR® An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Metipranolol Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Metoprolol Kapspargo Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Metronidazole Flagyl An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Midodrine Orvaten® An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Mifepristone Korlym An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Mirtazapine Mirataz An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Mizolastine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Mobocertinib Exkivity An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Modafinil Provigil An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Moricizine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Moxifloxacin Avelox An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Nadolol Corgard Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Nafarelin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Nebivolol Bystolic Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Nelfinavir Viracept An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Nilotinib An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Norepinephrine An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Norfloxacin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Nortriptyline Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Octreotide Bynfezia An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ofloxacin Floxin® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Olanzapine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ondansetron An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Opipramol Potentiated cardiovascular effects Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.